The Copenhagen Post | Novo stock surges on rival’s weak sales data by Ritzau

AI generated summary, Read the full article for complete information.

Novo Nordisk’s shares rose 5.4 % after data showed rival Eli Lilly’s new weight‑loss pill Foundayo delivered only 3,707 prescriptions in its second week, far fewer than Novo’s oral version of Wegovy, which recorded 18,410 prescriptions during the same period, prompting analysts to view Lilly’s launch as weak and boosting confidence in Novo’s product.

Read more: https://cphpost.dk/2026-04-25/business-education/business-business-education/novo-stock-surges-on-rivals-weak-sales-data/

#NovoNordisk #EliLilly #Foundayo #Wegovy #business #SørenLøntoftHansen

AI generated summary, Read the full article for complete information.

Flere insulinpreparater fra #NovoNordisk forsvinner fra markedet i løpet av året. Hvis du går på noen av de og ikke har tatt en prat med legen din ennå, gjør det, så er du forberedt og slipper noe stress når det skjer! https://diabetes.no/mer/nyheter-om-diabetes/nyheter-2026/insuliner-forsvinner--na-ma-du-bytte/

#diabetes #insulin #NorskTut #allheimen #helse

Adnkronos - ultimoratop: Farmaci, Olesen (Novo Nordisk): "Con ReMed raccolte 1,5 tonnellate di materiali plastici"

(Adnkronos) - Sull'ampliamento del progetto, 'obiettivo zero inquinanti nelle discariche'

Medications, Olesen (Novo Nordisk): "With ReMed, 1.5 tons of plastic materials were collected"

(Adnkronos) - Regarding the expansion of the project, 'objective zero pollutants in landfills'

#Olesen #NovoNordisk #ReMed #15tons

https://www.adnkronos.com/salute/farmaci-olesen-novo-nordisk-con-remed-raccolte-1-5-tonnellate-di-materiali-plastici_1C1gl8iLc63boU1vnkJumg

Lihavuuden hoito Wegovy-lääkkeellä pysyy toistaiseksi itse maksettavana

Hintalautakunta hylkäsi lääkeyhtiön hakemuksen perus­korvattavuudesta. Diabetesliitto harmittelee päätöstä.

https://yle.fi/a/74-20220774

#Lääkkeet #Lääketeollisuus #Painonhallinta #Novonordisk #Terveys #Talous

Millions Of Americans Are Losing Weight With GLP-1s. Here’s How That’s Changing Retail.

https://vid.freedif.org/w/ui4XcrHHK8TuVH7VWj85Mn

Why Novo Nordisk’s Weight Loss Pill Has Taken Off

https://vid.freedif.org/w/87SKdNnd3zKBYnKR9BgLck

THE DOUBLE-EDGED SWORD OF OZEMPIC

Ozempic users in the USA are reporting severe stomach issues like gastroparesis. Lawsuits claim the drug causes NAION. Learn about the risks.

#OzempicLawsuit, #DrugSideEffects, #Gastroparesis, #NAION, #NovoNordisk

https://newsletter.tf/ozempic-lawsuits-allege-serious-side-effects-usa/

New lawsuits are being filed against Ozempic makers due to serious stomach problems. This is happening as more people use it for weight loss.

#OzempicLawsuit, #DrugSideEffects, #Gastroparesis, #NAION, #NovoNordisk
https://newsletter.tf/ozempic-lawsuits-allege-serious-side-effects-usa/